Oxford Gene Technology develops lupus biomarker panel; Receptor identified to help measure cancer risk;

> Scientists at Boston Children's hospital believe urinary levels of hepatocyte growth factor, or HGF, could work as a biomarker to help detect arteriovenous malformations. Release

> The Translational Genomics Research Institute will work with Eastern-Bell Sports on a biomarker study of concussive injuries. Release

> Variations in the interleukin-1 receptor antagonist gene can be an accurate biomarker for the advance of knee osteoarthritis in some patients, Interleukin Genetics and the University of North Carolina have found. Item

> A receptor called integrin α4β1 could be a vital biomarker to help measure cancer risk, University of California, San Diego scientists have determined. Item

> Oxford Gene Technology, working with King's College London, has developed an autoantibody biomarker panel designed to improve the diagnosis of lupus. Release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.